TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17383011

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 403

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 403
Study: 14754626

Group type: EXPERIMENTAL
Intervention: Cane length of 0.92 m
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cane length of 1.22 m
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cane length of 1.37 m
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cane length of 1.67 m
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Block height
Number of subjects: 15
Study: 11431134

Group type: EXPERIMENTAL
Intervention: Testosterone supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physiologic testosterone replacement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Testosterone
Number of subjects: 0
Study: 9208343

Group type: EXPERIMENTAL
Intervention: Maalox 70 suspension (10 ml) with cerivastatin (200 micrograms)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg b.i.d. for 4 days) with cerivastatin (200 micrograms)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Cerivastatin (200 micrograms) alone
Number of subjects: 8
Study: 7708405

Group type: EXPERIMENTAL
Intervention: Nasal capsaicin treatment on the ipsilateral side
Number of subjects: 70

Group type: COMPARATOR
Intervention: Nasal capsaicin treatment on the contralateral side
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Nasal capsaicin treatment for chronic patients (ipsilateral and contralateral alternately)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Comparison of ipsilateral vs contralateral treatment
Number of subjects: 70
Study: 3616278

Group type: EXPERIMENTAL
Intervention: Single-dose trimethoprim 400 mg once
Number of subjects: 90

Group type: COMPARATOR
Intervention: Multi-dose trimethoprim 200 mg twice daily for five days
Number of subjects: 90
Study: 29629591

Group type: EXPERIMENTAL
Intervention: Dynamic Locking Blade Plate (DLBP)
Number of subjects: 106
Study: 26892939

Group type: EXPERIMENTAL
Intervention: Bitemporal ECT
Number of subjects: 138

Group type: COMPARATOR
Intervention: High-dose unilateral ECT
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 138
Study: 25460255

Group type: EXPERIMENTAL
Intervention: Cycled light (7 am-7 pm lights on, 7 pm-7 am lights off, n=17)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Dim light (lights off whenever the child is asleep, n=17)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Term infants (control group, n=14)
Number of subjects: 34
Study: 23813330

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 7
Study: 20299496

Group type: EXPERIMENTAL
Intervention: lopinavir/ritonavir monotherapy
Number of subjects: 72

Group type: COMPARATOR
Intervention: triple therapy including lopinavir/ritonavir
Number of subjects: 72
Study: 17597398

Group type: EXPERIMENTAL
Intervention: 10-day triple therapy
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: 10-day sequential regimen
Number of subjects: 282
Study: 16186262

Group type: EXPERIMENTAL
Intervention: Feedback + reminders
Number of subjects: 4138

Group type: COMPARATOR
Intervention: Control
Number of subjects: 4138

Group type: EXPERIMENTAL
Intervention: Feedback only
Number of subjects: 4138

Group type: EXPERIMENTAL
Intervention: Reminders only
Number of subjects: 4138
Study: 12517650

Group type: EXPERIMENTAL
Intervention: Intraabdominal irrigation with normal saline (500-1000 mL)
Number of subjects: 196

Group type: COMPARATOR
Intervention: No irrigation (Control)
Number of subjects: 196
Study: 10769584

Group type: EXPERIMENTAL
Intervention: Ramipril at a dose of 10 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vitamin E supplements at a dose of 400 UI/day
Number of subjects: 0
Study: 8804873

Group type: EXPERIMENTAL
Intervention: Triple therapy (colloidal bismuth subcitrate 480 mg/day plus metronidazole 750 mg/day and tetracycline 1000 mg/day for 4 weeks)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Omeprazole 40 mg/day for 8 weeks
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Triple therapy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Omeprazole
Number of subjects: 45
Study: 1617708

Group type: EXPERIMENTAL
Intervention: 4.5 mega U of pro-urokinase
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 6.5 mega U of pro-urokinase
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 500,000 U of urokinase plus 6.5 mega U of pro-urokinase
Number of subjects: 62

Group type: COMPARATOR
Intervention: All treatment groups
Number of subjects: 62
Study: 6496919

Group type: EXPERIMENTAL
Intervention: Heparin + 1000 units of purified human antithrombin III (AT III) concentrate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Heparin only
Number of subjects: 20
Study: 30039442

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Saccharated ferric oxide (SFO)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Both groups (FCM and SFO)
Number of subjects: 238
Study: 28527204

Group type: EXPERIMENTAL
Intervention: Low dose LEV (2.5 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher dose LEV (7.5 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26097215

Group type: EXPERIMENTAL
Intervention: Abatacept (10 mg/kg every 4 weeks)
Number of subjects: 190
Study: 24199969

Group type: EXPERIMENTAL
Intervention: Qigong training (twice a week for 10 weeks)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 34
Study: 21891890

Group type: EXPERIMENTAL
Intervention: HA+200 μg drug solution of ALN
Number of subjects: 15

Group type: COMPARATOR
Intervention: Hydroxyapatite (HA) bone graft material
Number of subjects: 15
Study: 19696601

Group type: EXPERIMENTAL
Intervention: Individualized Acu/Moxa treatment
Number of subjects: 29

Group type: COMPARATOR
Intervention: Sham/placebo Acu/Moxa
Number of subjects: 29
Study: 16754631

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12943880

Group type: EXPERIMENTAL
Intervention: Jo heparin‐coated stent deployment
Number of subjects: 202

Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 202
Study: 10781272

Group type: EXPERIMENTAL
Intervention: Episcleral anesthesia
Number of subjects: 66

Group type: COMPARATOR
Intervention: Peribulbar anesthesia
Number of subjects: 66
Study: 8793794

Group type: COMPARATOR
Intervention: Single-use cellulose dialyzers
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Reuse cellulose dialyzers
Number of subjects: 37
Study: 1632658

Group type: EXPERIMENTAL
Intervention: Piroxicam 20 mg/day by mouth
Number of subjects: 21
Study: 6489428

Group type: EXPERIMENTAL
Intervention: Acetaminophen 12‐14 mg/kg
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Acetaminophen 22‐27 mg/kg
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Acetaminophen repeated doses every 4 or 8 h for 1 to 3 days
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Acetaminophen repeated doses
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 21
Study: 31581416

Group type: EXPERIMENTAL
Intervention: Greater morning snacking
Number of subjects: 2265

Group type: EXPERIMENTAL
Intervention: Greater evening snacking
Number of subjects: 2265

Group type: EXPERIMENTAL
Intervention: Mid-day snacking
Number of subjects: 2265
Study: 29020483

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT), applied three times weekly.
Number of subjects: 216
Study: 25706661

Group type: EXPERIMENTAL
Intervention: 6-minute step test (6MST)
Number of subjects: 91
Study: 24510352

Group type: EXPERIMENTAL
Intervention: Vertical visual distractor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Horizontal visual distractor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-contrast visual distractor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-contrast visual distractor
Number of subjects: 0
Study: 22703579

Group type: EXPERIMENTAL
Intervention: Partial Meal Replacement (PMR)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Partial Meal Replacement with Inulin (PMR + I)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Inulin (INU)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Low Calorie Diet (LCD)
Number of subjects: 144
Study: 20713433

Group type: EXPERIMENTAL
Intervention: Broccoli intake (250 g/day)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 27
Study: 17553051

Group type: EXPERIMENTAL
Intervention: Combination of amorolfine hydrochloride 5% nail lacquer once weekly for 12 months plus terbinafine 250 mg once daily for 3 months (AT group)
Number of subjects: 249

Group type: COMPARATOR
Intervention: Terbinafine alone once daily for 3 months (T group)
Number of subjects: 249
Study: 15637528

Group type: EXPERIMENTAL
Intervention: Talinolol with D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS) (0.04%)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Talinolol with Poloxamer 188 (0.8%)
Number of subjects: 9
Study: 12117037

Group type: EXPERIMENTAL
Intervention: Airmax inhaler at fast flow rate (60 l min(‐1))
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Turbuhaler at fast flow rate (60 l min(‐1))
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Airmax inhaler at slow flow rate (30 l min(‐1))
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Turbuhaler at slow flow rate (30 l min(‐1))
Number of subjects: 12

Group type: COMPARATOR
Intervention: pMDI at slow flow rate (30 l min(‐1))
Number of subjects: 12
Study: 10662396

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 240

Group type: COMPARATOR
Intervention: Usual antibacterial care
Number of subjects: 240
Study: 7487784

Group type: EXPERIMENTAL
Intervention: Psychiatric case management using an assertive community treatment model involving general practitioners
Number of subjects: 59

Group type: COMPARATOR
Intervention: Standard outpatient care
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Psychiatric case management
Number of subjects: 59
Study: 2151518

Group type: EXPERIMENTAL
Intervention: Domperidone (DMP; 20 mg orally)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 7422533

Group type: EXPERIMENTAL
Intervention: Oral pentaerythritol tetranitrate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral pentaerythritol tetranitrate (high dosage)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31667917

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (600, 2000, and 4000 IU d-1 for 16 weeks)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 31127705

Group type: EXPERIMENTAL
Intervention: Acellular amniotic membrane seeded with Wharton's jelly mesenchymal stem cells (WJSCs) for 9 days, every 3 days
Number of subjects: 5
Study: 28322505

Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide (10% CP/PF) (Opalescence PF)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 6% hydrogen peroxide (6% HP/Go) (Opalescence Go)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Negative control
Number of subjects: 92
Study: 25562379

Group type: EXPERIMENTAL
Intervention: DSM-IV criteria for acute stress disorder (ASD)
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: DSM-5 criteria for acute stress disorder (ASD)
Number of subjects: 596

Group type: COMPARATOR
Intervention: Comparison of DSM-IV and DSM-5 ASD definitions
Number of subjects: 596

Group type: COMPARATOR
Intervention: Sensitivity for psychiatric disorders
Number of subjects: 596
Study: 22823069

Group type: EXPERIMENTAL
Intervention: Enhanced Internet program (EI; N = 25)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Standard Internet program (SI; N = 28)
Number of subjects: 53
Study: 21297567

Group type: EXPERIMENTAL
Intervention: BCAA (300 mg . kg . day ‐1)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 7
Study: 19444412

Group type: EXPERIMENTAL
Intervention: Insertion of a central venous catheter in patients with coagulopathy
Number of subjects: 196
Study: 16720746

Group type: EXPERIMENTAL
Intervention: Self-reported depressive symptoms and vitality scores
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Weight change
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Vitality and depressive symptoms
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Depressive symptoms
Number of subjects: 266
Study: 11828226

Group type: EXPERIMENTAL
Intervention: Treadmill walking at an intensity of 65-75% VO(2peak)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Submaximal exercise
Number of subjects: 18

Group type: COMPARATOR
Intervention: Quiet rest
Number of subjects: 18
Study: 10406241

Group type: EXPERIMENTAL
Intervention: ASA/PC (Aspirin associated with phosphatidylcholine)
Number of subjects: 16

Group type: COMPARATOR
Intervention: ASA (Aspirin alone)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: ASA
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: ASA/PC
Number of subjects: 16
Study: 7590638

Group type: COMPARATOR
Intervention: Low protein‐high fat evening meal (5% protein, 60% fat, 35% carbohydrate)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High protein‐low fat evening meal (35% protein, 30% fat, 35% carbohydrate)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 8
Study: 2119897

Group type: EXPERIMENTAL
Intervention: (NANP)3-TT
Number of subjects: 123

Group type: COMPARATOR
Intervention: TT alone (Control)
Number of subjects: 123
Study: 7228446

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Mianserin
Number of subjects: 10
Study: 31777299

Group type: EXPERIMENTAL
Intervention: Injectable colistin plus nebulized colistin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Injectable colistin plus nebulized tobramycin
Number of subjects: 60
Study: 28355973

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: CBT integrated with motivational interviewing
Number of subjects: 85

Group type: COMPARATOR
Intervention: Low initial patient-rated alliance and low convergence
Number of subjects: 85
Study: 28351376

Group type: EXPERIMENTAL
Intervention: Bespoke user‐tested patient information sheet (PIS)
Number of subjects: 6900

Group type: EXPERIMENTAL
Intervention: Template‐developed patient information sheet (PIS)
Number of subjects: 6900

Group type: COMPARATOR
Intervention: Control patient information sheet (PIS)
Number of subjects: 6900
Study: 26022813

Group type: EXPERIMENTAL
Intervention: Dalcetrapib (a cholesteryl ester transfer protein inhibitor)
Number of subjects: 16818

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg daily
Number of subjects: 16818
Study: 24016503

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon (PCB)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Conventional balloon angioplasty (BA)
Number of subjects: 208
Study: 21173357

Group type: EXPERIMENTAL
Intervention: Continuous quality improvement interventions
Number of subjects: 361328

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 361328
Study: 19065845

Group type: EXPERIMENTAL
Intervention: Nasal masks with exhaust vents (EV)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Facial masks with exhaust vents (EV)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Spacers attached to nasal hermetic masks
Number of subjects: 5
Study: 16373526

Group type: EXPERIMENTAL
Intervention: Proxy consent for incapacitated adults
Number of subjects: 2445
Study: 12602423

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral therapy (CBT)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Discussion group (DG)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Waiting period
Number of subjects: 75
Study: 10430816

Group type: EXPERIMENTAL
Intervention: Oral antihyperglycemic agents
Number of subjects: 0
Study: 7558380

Group type: EXPERIMENTAL
Intervention: Testosterone enanthate, 200 mg IM, weekly injections during the suppression (6‐month) and efficacy (12‐month) phases.
Number of subjects: 670
Study: 2331243

Group type: EXPERIMENTAL
Intervention: Biofeedback training in temporal artery constriction during headaches
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Biofeedback training in temporal artery constriction during stress periods
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Biofeedback training to dilate the temporal arteries during stress periods
Number of subjects: 23
Study: 496621

Group type: EXPERIMENTAL
Intervention: 1000‐IU vitamin E capsules (alpha‐tocopherol) administered daily for 28 days
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 1000‐IU vitamin E capsules (alpha‐tocopherol)
Number of subjects: 35
Study: 31787421

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 163
Study: 30650245

Group type: EXPERIMENTAL
Intervention: Group-based mindfulness-based cognitive therapy (MBCT)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Therapist competence
Number of subjects: 84

Group type: COMPARATOR
Intervention: Group cohesion
Number of subjects: 84
Study: 28574379

Group type: COMPARATOR
Intervention: Standard therapy for DFS
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Cytoflavin 10 ml 0.9% NaCl 200 ml for 10 days, followed by 2 tablets 2 times per day orally for one month
Number of subjects: 97
Study: 27789061

Group type: EXPERIMENTAL
Intervention: Support intervention (referral to a weight management group, 12 sessions of 1 hour each, once per week)
Number of subjects: 1882

Group type: COMPARATOR
Intervention: Advice intervention (advised that health would benefit from weight loss)
Number of subjects: 1882

Group type: EXPERIMENTAL
Intervention: Support intervention
Number of subjects: 1882

Group type: COMPARATOR
Intervention: Advice intervention
Number of subjects: 1882

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 1882
Study: 25029675

Group type: EXPERIMENTAL
Intervention: Multi-ingredient supplement enriched with l-glutamine and l-carnitine-l-tartrate
Number of subjects: 10

Group type: COMPARATOR
Intervention: Carbohydrate supplement
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Multi-ingredient supplement
Number of subjects: 10
Study: 22278200

Group type: EXPERIMENTAL
Intervention: Exchange transfusion therapy
Number of subjects: 6
Study: 19056578

Group type: EXPERIMENTAL
Intervention: Glutamine (30 g)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Oral glucose (75 g)
Number of subjects: 24
Study: 17242107

Group type: EXPERIMENTAL
Intervention: Stimulating catheter (SC group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional catheter (CC group)
Number of subjects: 40
Study: 15710594

Group type: EXPERIMENTAL
Intervention: Morel's prognostic scoring system
Number of subjects: 92
Study: 12475466

Group type: EXPERIMENTAL
Intervention: Carvedilol (0.01 mg/kg/day titrated up to 0.2 mg/kg/day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 9535429

Group type: EXPERIMENTAL
Intervention: 75 mg aspirin daily
Number of subjects: 926

Group type: EXPERIMENTAL
Intervention: Felodipine 5 mg daily
Number of subjects: 926

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 926
Study: 7608438

Group type: EXPERIMENTAL
Intervention: L-carnitine (9 g/day intravenously for the first 5 days, then 6 g/day orally for 12 months)
Number of subjects: 472

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: L-carnitine
Number of subjects: 472
Study: 29436337

Group type: EXPERIMENTAL
Intervention: Rifaximin for 42 days
Number of subjects: 186

Group type: COMPARATOR
Intervention: Standard care without rifaximin
Number of subjects: 186
Study: 27330709

Group type: EXPERIMENTAL
Intervention: SRP + PDT (with diode laser 808 nm, 0.5 W)
Number of subjects: 18

Group type: COMPARATOR
Intervention: SRP (scaling and root planning)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Laser + SRP (with diode laser 808 nm, 1 W)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Diode laser (810n m wavelength, 1.5 W and 320 μm fiber)
Number of subjects: 18
Study: 26241700

Group type: EXPERIMENTAL
Intervention: CYP24A1 rs927650 T allele
Number of subjects: 1188

Group type: EXPERIMENTAL
Intervention: CYP24A1 rs35051736
Number of subjects: 1188

Group type: EXPERIMENTAL
Intervention: CYP24A1 rs2296241
Number of subjects: 1188

Group type: EXPERIMENTAL
Intervention: CYP24A1 rs2762939
Number of subjects: 1188
Study: 23958241

Group type: EXPERIMENTAL
Intervention: Pioglitazone, 45 mg/d for 6 months
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Metformin, 2 g/day added after pioglitazone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 21168835

Group type: EXPERIMENTAL
Intervention: Endoscopic trimodal imaging (ETMI)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Standard video endoscopy (SVE)
Number of subjects: 99
Study: 19046778

Group type: EXPERIMENTAL
Intervention: Bilingual education (spoken + sign language)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Spoken language education
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both groups (bilingual and spoken language)
Number of subjects: 18
Study: 16962109

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided embryo transfer
Number of subjects: 730

Group type: COMPARATOR
Intervention: Embryo transfer based on previous ultrasonographic length measurement
Number of subjects: 730
Study: 15236870

Group type: EXPERIMENTAL
Intervention: 5x5Gy short-term irradiation
Number of subjects: 316

Group type: COMPARATOR
Intervention: Chemoradiation to a total dose of 50.4Gy (1.8Gy per fraction) with two courses of bolus 5-fluorouracil and leucovorin
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Chemoradiation
Number of subjects: 316
Study: 11736860

Group type: EXPERIMENTAL
Intervention: 4 mg diazepam i.n.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 7 mg diazepam i.n.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 5 mg intravenous diazepam
Number of subjects: 8

Group type: COMPARATOR
Intervention: Intranasal placebo
Number of subjects: 8
Study: 9431617

Group type: EXPERIMENTAL
Intervention: Cotrel‐Dubousset instrumentation
Number of subjects: 130

Group type: COMPARATOR
Intervention: No instrumentation
Number of subjects: 130